Furthermore, TREM2 increases β-catenin phosphorylation by activating GSK-3β, which suppresses β-catenin accumulation and TCF4 transcriptional activity, resulting in the downregulation of tumorigenicity in colon cancer cells. This evidence concerns the gene GSK3B and malignant colon neoplasm.